ABCL
Price
$4.47
Change
+$0.57 (+14.62%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
1.34B
19 days until earnings call
ZLAB
Price
$33.58
Change
-$2.43 (-6.75%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
3.82B
19 days until earnings call
Interact to see
Advertisement

ABCL vs ZLAB

Header iconABCL vs ZLAB Comparison
Open Charts ABCL vs ZLABBanner chart's image
AbCellera Biologics
Price$4.47
Change+$0.57 (+14.62%)
Volume$79.47K
Capitalization1.34B
Zai Lab
Price$33.58
Change-$2.43 (-6.75%)
Volume$13.88K
Capitalization3.82B
ABCL vs ZLAB Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ZLAB commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ZLAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (ABCL: $3.90 vs. ZLAB: $36.01)
Brand notoriety: ABCL and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 96% vs. ZLAB: 149%
Market capitalization -- ABCL: $1.34B vs. ZLAB: $3.82B
ABCL [@Biotechnology] is valued at $1.34B. ZLAB’s [@Biotechnology] market capitalization is $3.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLAB is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while ZLAB’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 5 bearish.
  • ZLAB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than ZLAB.

Price Growth

ABCL (@Biotechnology) experienced а -8.24% price change this week, while ZLAB (@Biotechnology) price change was +5.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

ZLAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLAB($3.83B) has a higher market cap than ABCL($1.34B). ZLAB YTD gains are higher at: 37.495 vs. ABCL (33.106). ABCL has higher annual earnings (EBITDA): -211.2M vs. ZLAB (-236.44M). ZLAB has more cash in the bank: 757M vs. ABCL (605M). ABCL has less debt than ZLAB: ABCL (67.8M) vs ZLAB (192M). ZLAB has higher revenues than ABCL: ZLAB (418M) vs ABCL (23.1M).
ABCLZLABABCL / ZLAB
Capitalization1.34B3.83B35%
EBITDA-211.2M-236.44M89%
Gain YTD33.10637.49588%
P/E RatioN/AN/A-
Revenue23.1M418M6%
Total Cash605M757M80%
Total Debt67.8M192M35%
FUNDAMENTALS RATINGS
ZLAB: Fundamental Ratings
ZLAB
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLZLAB
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLNNX25.200.22
+0.88%
MFS Global New Discovery R6
JRAIX94.290.66
+0.70%
Janus Henderson Research I
SEHAX15.490.10
+0.65%
SEI US Equity Factor Allocation A (SIIT)
MMPCX20.780.12
+0.58%
NYLI WMC Value Class C
MXXVX37.470.21
+0.56%
Matthew 25

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-3.94%
CRSP - ABCL
63%
Loosely correlated
-0.09%
RXRX - ABCL
59%
Loosely correlated
+5.75%
BEAM - ABCL
56%
Loosely correlated
+1.89%
ABSI - ABCL
56%
Loosely correlated
+5.11%
VCYT - ABCL
56%
Loosely correlated
-3.77%
More